Wenger Vieli advised Xeltis AG on the deal. The Chinese company Grand Pharmaceutical Group Ltd (0512.HK) has committed to invest €15 million in equity and license...
Xeltis AG’s €15 Million Series D2 Financing Round
Xeltis’ €15 Million Quasi-Equity Financing From EIB
Wenger Vieli advised Xeltis on the deal. Xeltis is a pioneering medtech firm developing medical devices enabling cardiovascular restoration. The Swiss/Dutch university spin-off landed a €15...